Last week, the hemp industry in the US received a critical vote of support thanks to a banking legislator, but an advocate for the industry says there’s still a long way to go for the market.

In an interview with the Investing News Network (INN), Jonathan Miller, general counsel to the US Hemp Roundtable, a lobbying and support group for the hemp industry, said a key bill currently waiting at the US Senate will really open the doors to the entire hemp space from a banking perspective.


That’s the Secure and Fair Enforcement (SAFE) Banking Act, which the US Hemp Roundtable is currently working on lobbying at the Senate level.

On December 3, a collection of bank regulators across government levels issued new guidance confirming the legal status of the hemp market in terms of banking services.

This guidance makes it so there isn’t a need to file suspicious activity reports for bank customers conducting business in the hemp industry.

The regulators include: the board of governors of the Federal Reserve System, the Federal Deposit Insurance Corporation, the Financial Crimes Enforcement Network, the Office of the Comptroller of the Currency and the Conference of State Bank Supervisors.

Miller said this change represents a major win for the hemp industry since it opens the doors for financial institutions to not be as worried when it comes to doing business within the space.

“By putting out this guidance the financial regulators have said, ‘Don’t worry, we’re not going to audit you for simply doing business with hemp or a hemp company,'” he told INN.

The US Hemp Roundtable represents 90 companies across the US, according to Miller. The hemp advocate explained banks had been afraid of getting audited for doing business with a hemp company.

According to Miller, the farm bill makes it “perfectly clear” that hemp is not a controlled substance, which should’ve been the “marching orders” for banks and other financial institutions to normalize business with hemp companies.

Still, hemp, and more critically, hemp-derived cannabidiol products, has seen a boom in the market thanks to the removal of hemp from the federal ban on marijuana as part of the farm bill of 2018.

When asked what the chances are of the bill actually getting approved by the Senate, Miller said he is cautiously optimistic about its approval, but said the bill will be more closely looked at in 2020.

The SAFE Banking Act cleared the House of Representatives back in September; since then, it’s been a slow path for the bill at the Senate level.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

Trial designed to investigate the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (“Cardiol” or the “Company”), a clinical-stage biotechnology company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease, today announced the formation of the Data Safety Monitoring Committee (“DSMC”) and the Clinical Endpoint Committee (“CEC”) for the Company’s Phase IIIII trial in high-risk patients hospitalized with COVID-19 at clinical centers throughout the United States.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (“ HempFusion ” or the “ Company ”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has entered into a large-scale distribution agreement with Fullscript.com (“ Fullscript ”), a leading eCommerce platform that allows health professionals to dispense professional-grade natural health products. Fullscript is one of the largest distributors in the category, providing nutritional supplements to over 80,000 practitioners and over 600,000 patients across the United States and Canada.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005282/en/

Keep reading... Show less

Progressive Planet Solutions Inc. (TSXV: PLAN) (“PLAN” or “Progressive Planet”), announces that, further to its news releases dated December 22, 2020 and January 7, 2021 the Company has closed its non-brokered private placement financing comprising of 7,500,000 units, at $0.10 per unit, for total gross proceeds of $750,000 .

Keep reading... Show less

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

 Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE: RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that is has entered into an agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), pursuant to which the Underwriters have agreed to purchase, on a bought-deal basis, 20,000,000 units (the ” Equity Units “) at a price of $0.50 per Equity Unit for gross proceeds to the Company of $10,000,000 (the ” Offering “).

Keep reading... Show less